High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review. (Q38058545)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137006%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137006%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

liver transplantation

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

George Papatheodoridis

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137006%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

E Cholongitas

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137006%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

0 references

publication date

8 November 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137006%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

American Journal of Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137006%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137006%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

353-362

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137006%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137006%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Current management of hepatitis B virus infection before and after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Management of hepatitis B in liver transplantation patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

The role of entecavir in preventing hepatitis B recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Posttransplantation hepatitis B prophylaxis with combination oral nucleoside and nucleotide analog therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Anti-hepatitis B surface immunoglobulin reduction in early postoperative period after liver transplantation in hepatitis B virus-positive patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Efficacy and safety of entecavir and/or tenofovir for prophylaxis and treatment of hepatitis B recurrence post-liver transplant

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Prevention and risk factors of the HBV recurrence after orthotopic liver transplantation: 160 cases follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Prevention of hepatitis B recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis B immunoglobulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Adherence to Lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Evolving experience of hepatitis B virus prophylaxis in liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Prevention of hepatitis B virus reinfection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Hepatitis B virus resistance to antiviral drugs: where are we going?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Review article: current antiviral therapy of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04315.X

21 January 2018

Identifiers

10.1111/J.1600-6143.2012.04315.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137006%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137006%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38058545&oldid=1540165756"